Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes

被引:45
|
作者
Leu, JH
Yan, SJ
Lee, TF
Chou, CM
Chen, ST
Hwang, PP
Chou, CK
Huang, CJ
机构
[1] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
[2] Acad Sinica, Inst Zool, Taipei 115, Taiwan
[3] Vet Gen Hosp, Dept Med Res, Taipei 11217, Taiwan
关键词
D O I
10.1089/10445490050085924
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported the isolation of the JAK1 gene from the round-spotted pufferfish, In the present study, nle cloned and characterized genomic sequences encoding pufferfish JAK2, JAK3, and TYK2, which are other members of JAK family, To our knowledge, this is the first report to demonstrate the existence of four JAK genes in fish. All pufferfish JAK genes except JAK1 are composed of 24 exons; JAK1 has an additional exon, A comparison of the exon-intron organization of these genes revealed that the splice sites of JAK genes are nearly identical. In addition, all pufferfish JAK genes have one intron in the 5' untranslated region. Taken together, these data suggest that the pufferfish JAK genes may have evolved from a common ancestor. By 5' rapid amplification of cDNA ends and sequence analysis, me deduced the promoter regions for all JAK genes and found they do not contain typical TATA or CCAAT boxes but rather numerous other potential binding sites for transcription factors. Interestingly, the TYK2 gene is linked to CDC37 in a head-to-tail manner with a small intergenic region of 292 bp, Within this region, there are two potential binding sites for transcriptional factors such as c-Myb and NF-IL6, The putative promoter regions of all JAK genes were tested either in a carp CF cell line or in zebrafish embryos using CAT or lacZ as reporter genes. Both assays confirmed the transcriptional activities of these promoters in vitro and in vivo.
引用
收藏
页码:431 / 446
页数:16
相关论文
共 50 条
  • [21] A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor
    Menet, Christel J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8594 - 8596
  • [22] Variants in the JAK1 and JAK2 genes in the risk and prognosis of patients with cutaneous melanoma
    Carvalho, B. F.
    Gomez, G. V. B.
    Lourenco, G. J.
    Moraes, A. M. D.
    Lima, C. S. Passos
    ANNALS OF ONCOLOGY, 2019, 30 : 14 - 14
  • [23] Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
    Alfonso Quintás-Cardama
    Taghi Manshouri
    Zeev Estrov
    David Harris
    Ying Zhang
    Amos Gaikwad
    Hagop M. Kantarjian
    Srdan Verstovsek
    Investigational New Drugs, 2011, 29 : 818 - 826
  • [24] Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
    Quintas-Cardama, Alfonso
    Manshouri, Taghi
    Estrov, Zeev
    Harris, David
    Zhang, Ying
    Gaikwad, Amos
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 818 - 826
  • [25] CXCL12 signaling is independent of Jak2 and Jak3
    Moriguchi, M
    Hissong, BD
    Gadina, M
    Yamaoka, K
    Tiffany, HL
    Murphy, PM
    Candotti, F
    O'Shea, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17408 - 17414
  • [26] Pyrrolo[1,2-f]triazines as JAK2 inhibitors: Achieving potency and selectivity for JAK2 over JAK3
    Harikrishnan, Lalgudi S.
    Kamau, Muthoni G.
    Wan, Honghe
    Inghrim, Jennifer A.
    Zimmermann, Kurt
    Sang, Xiaopeng
    Mastalerz, Harold A.
    Johnson, Walter L.
    Zhang, Guifen
    Lombardo, Louis J.
    Poss, Michael A.
    Trainor, George L.
    Tokarski, John S.
    Lorenzi, Matthew V.
    You, Dan
    Gottardis, Marco M.
    Baldwin, Kathy F.
    Lippy, Jonathan
    Nirschl, David S.
    Qiu, Ruhui
    Miller, Arthur V.
    Khan, Javed
    Sack, John S.
    Purandare, Ashok V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1425 - 1428
  • [27] Molecular alterations in JAK1 and JAK2 genes in head and neck squamous cell carcinoma
    Carvalho, Thais G.
    Carvalho, Andre Lopes
    Vettore, Andre Luiz
    CANCER RESEARCH, 2012, 72
  • [28] Prevention of Islet Inflammatory Stress with JAK1/JAK2 Inhibitors
    Watson, Eleanor
    Waibel, Michaela
    Trivedi, Prerak
    Pappas, Evan
    Fynch, Stacey
    Sutherland, Robyn
    Kay, Thomas
    Thomas, Helen
    TRANSPLANTATION, 2018, 102 : S370 - S370
  • [29] JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation - Cross-talk with IGF1 receptor
    Staerk, J
    Kallin, A
    Demoulin, JB
    Vainchenker, W
    Constantinescu, SN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (51) : 41893 - 41899
  • [30] INTERACTION OF JAK1 AND JAK3 TYROSINE KINASES WITH THE IL2 RECEPTOR COMPLEX
    KIRKEN, RA
    RUI, H
    MALABARBA, MG
    KAWAMURA, M
    OSHEA, JJ
    FARRAR, WL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 38 - 38